Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Matthew T. Hall writes that Kennedy’s U-turns on vaccinations and abortions should concern everyone following his close ...
Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...
Robert F. Kennedy Jr.—whose history of anti-vaccine rhetoric has had the healthcare and biopharma industries on edge—was ...
Norovirus is highly infectious and causing a lot of illness this winter. Several vaccine candidates are making their way through clinical trials.
4d
Baby Center (worldwide) on MSNHere's the vaccine schedule to follow for your baby or older childVaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...
The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...
9d
What to Expect on MSNShould You Get the COVID-19 Vaccine for Your Baby or Toddler?Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.
Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...
The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results